Research ExplorerPublicationsComplications and mortality after catheter ablation of ventr...

Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score

Standard

Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score. / Mathew, Shibu; Fink, Thomas; Feickert, Sebastian; Inaba, Osamu; Hashiguchi, Naotaka; Schlüter, Michael; Wohlmuth, Peter; Wissner, Erik; Tilz, Roland Richard; Heeger, Christian-Hendrik; Rottner, Laura; Reissmann, Bruno; Rillig, Andreas; Metzner, Andreas; Maurer, Tilman; Kuck, Karl-Heinz; Ouyang, Feifan.

In: CLIN RES CARDIOL, Vol. 111, No. 5, 05.2022, p. 530-540.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Mathew, S, Fink, T, Feickert, S, Inaba, O, Hashiguchi, N, Schlüter, M, Wohlmuth, P, Wissner, E, Tilz, RR, Heeger, C-H, Rottner, L, Reissmann, B, Rillig, A, Metzner, A, Maurer, T, Kuck, K-H & Ouyang, F 2022, 'Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score', CLIN RES CARDIOL, vol. 111, no. 5, pp. 530-540. https://doi.org/10.1007/s00392-021-01902-2

APA

Mathew, S., Fink, T., Feickert, S., Inaba, O., Hashiguchi, N., Schlüter, M., Wohlmuth, P., Wissner, E., Tilz, R. R., Heeger, C-H., Rottner, L., Reissmann, B., Rillig, A., Metzner, A., Maurer, T., Kuck, K-H., & Ouyang, F. (2022). Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score. CLIN RES CARDIOL, 111(5), 530-540. https://doi.org/10.1007/s00392-021-01902-2

Vancouver

Mathew S, Fink T, Feickert S, Inaba O, Hashiguchi N, Schlüter M et al. Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score. CLIN RES CARDIOL. 2022 May;111(5):530-540. https://doi.org/10.1007/s00392-021-01902-2

Bibtex

@article{dfa10dc16df3495b8b316b7c8d5e26d5,
title = "Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score",
abstract = "AIMS: Catheter ablation of ventricular arrhythmias (VA) has proven to be an effective therapeutic option for secondary arrhythmia prophylaxis. We sought to assess the procedural efficacy, safety and in-hospital mortality of a large patient cohort with and without structural heart disease undergoing VA ablation.METHODS: A total of 1417 patients (804 patients with structural heart disease) undergoing 1792 endo- and epicardial procedures were analyzed. Multivariable risk factor analysis for occurrence of major complications and intrahospital mortality was obtained and a score to allow preprocedural risk assessment for patients undergoing VA ablation procedures was established.RESULTS: Major complication occurred in 4.4% of all procedures and significantly more often in patients with structural heart disease than in structurally normal hearts (6.0 vs. 1.8%). The frequency of these periprocedural complications was significantly different between procedures with sole right ventricular and a combination of RV and LV access (0.5 vs. 3.1%). The most common complication was cardiac tamponade in 46 cases (3.0%). Intrahospital death was observed in 32 patients (1.8%). Logistic regression model revealed presence of ischemic heart disease, epicardial ablation, presence of oral anticoagulation or dual antiplatelet therapy as independent risk factors for the occurrence of complications or intrahospital death, while a history of previous heart surgery was an independent predictor with a decreased risk. Based on this analysis a risk score incorporating 5 standard variables was established to predict the occurrence of complications and intrahospital mortality.CONCLUSIONS: Safety of VA catheter ablation mainly relies on patient baseline characteristics and the type of access into the ventricles or epicardial space.",
author = "Shibu Mathew and Thomas Fink and Sebastian Feickert and Osamu Inaba and Naotaka Hashiguchi and Michael Schl{\"u}ter and Peter Wohlmuth and Erik Wissner and Tilz, {Roland Richard} and Christian-Hendrik Heeger and Laura Rottner and Bruno Reissmann and Andreas Rillig and Andreas Metzner and Tilman Maurer and Karl-Heinz Kuck and Feifan Ouyang",
note = "{\textcopyright} 2021. The Author(s).",
year = "2022",
month = may,
doi = "10.1007/s00392-021-01902-2",
language = "English",
volume = "111",
pages = "530--540",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "5",

}

RIS

TY - JOUR

T1 - Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score

AU - Mathew, Shibu

AU - Fink, Thomas

AU - Feickert, Sebastian

AU - Inaba, Osamu

AU - Hashiguchi, Naotaka

AU - Schlüter, Michael

AU - Wohlmuth, Peter

AU - Wissner, Erik

AU - Tilz, Roland Richard

AU - Heeger, Christian-Hendrik

AU - Rottner, Laura

AU - Reissmann, Bruno

AU - Rillig, Andreas

AU - Metzner, Andreas

AU - Maurer, Tilman

AU - Kuck, Karl-Heinz

AU - Ouyang, Feifan

N1 - © 2021. The Author(s).

PY - 2022/5

Y1 - 2022/5

N2 - AIMS: Catheter ablation of ventricular arrhythmias (VA) has proven to be an effective therapeutic option for secondary arrhythmia prophylaxis. We sought to assess the procedural efficacy, safety and in-hospital mortality of a large patient cohort with and without structural heart disease undergoing VA ablation.METHODS: A total of 1417 patients (804 patients with structural heart disease) undergoing 1792 endo- and epicardial procedures were analyzed. Multivariable risk factor analysis for occurrence of major complications and intrahospital mortality was obtained and a score to allow preprocedural risk assessment for patients undergoing VA ablation procedures was established.RESULTS: Major complication occurred in 4.4% of all procedures and significantly more often in patients with structural heart disease than in structurally normal hearts (6.0 vs. 1.8%). The frequency of these periprocedural complications was significantly different between procedures with sole right ventricular and a combination of RV and LV access (0.5 vs. 3.1%). The most common complication was cardiac tamponade in 46 cases (3.0%). Intrahospital death was observed in 32 patients (1.8%). Logistic regression model revealed presence of ischemic heart disease, epicardial ablation, presence of oral anticoagulation or dual antiplatelet therapy as independent risk factors for the occurrence of complications or intrahospital death, while a history of previous heart surgery was an independent predictor with a decreased risk. Based on this analysis a risk score incorporating 5 standard variables was established to predict the occurrence of complications and intrahospital mortality.CONCLUSIONS: Safety of VA catheter ablation mainly relies on patient baseline characteristics and the type of access into the ventricles or epicardial space.

AB - AIMS: Catheter ablation of ventricular arrhythmias (VA) has proven to be an effective therapeutic option for secondary arrhythmia prophylaxis. We sought to assess the procedural efficacy, safety and in-hospital mortality of a large patient cohort with and without structural heart disease undergoing VA ablation.METHODS: A total of 1417 patients (804 patients with structural heart disease) undergoing 1792 endo- and epicardial procedures were analyzed. Multivariable risk factor analysis for occurrence of major complications and intrahospital mortality was obtained and a score to allow preprocedural risk assessment for patients undergoing VA ablation procedures was established.RESULTS: Major complication occurred in 4.4% of all procedures and significantly more often in patients with structural heart disease than in structurally normal hearts (6.0 vs. 1.8%). The frequency of these periprocedural complications was significantly different between procedures with sole right ventricular and a combination of RV and LV access (0.5 vs. 3.1%). The most common complication was cardiac tamponade in 46 cases (3.0%). Intrahospital death was observed in 32 patients (1.8%). Logistic regression model revealed presence of ischemic heart disease, epicardial ablation, presence of oral anticoagulation or dual antiplatelet therapy as independent risk factors for the occurrence of complications or intrahospital death, while a history of previous heart surgery was an independent predictor with a decreased risk. Based on this analysis a risk score incorporating 5 standard variables was established to predict the occurrence of complications and intrahospital mortality.CONCLUSIONS: Safety of VA catheter ablation mainly relies on patient baseline characteristics and the type of access into the ventricles or epicardial space.

U2 - 10.1007/s00392-021-01902-2

DO - 10.1007/s00392-021-01902-2

M3 - SCORING: Journal article

C2 - 34318341

VL - 111

SP - 530

EP - 540

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 5

ER -